226 related articles for article (PubMed ID: 22351942)
1. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
2. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A
Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.
Meng Q; Rani MR; Sugalski JM; Judge CJ; Phat S; Rodriguez B; Blanton RE; Anthony DD
J Infect Dis; 2014 May; 209(10):1591-601. PubMed ID: 24302757
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.
Oliviero B; Mele D; Degasperi E; Aghemo A; Cremonesi E; Rumi MG; Tinelli C; Varchetta S; Mantovani S; Colombo M; Mondelli MU
J Hepatol; 2013 Jul; 59(1):38-44. PubMed ID: 23499727
[TBL] [Abstract][Full Text] [Related]
6. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy.
Lee S; Watson MW; Flexman JP; Cheng W; Hammond T; Price P
J Med Virol; 2010 Apr; 82(4):568-74. PubMed ID: 20166183
[TBL] [Abstract][Full Text] [Related]
7. Activation of natural killer cells by hepatitis C virus particles in vitro.
Farag MM; Weigand K; Encke J; Momburg F
Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
[TBL] [Abstract][Full Text] [Related]
8. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.
Edlich B; Ahlenstiel G; Zabaleta Azpiroz A; Stoltzfus J; Noureddin M; Serti E; Feld JJ; Liang TJ; Rotman Y; Rehermann B
Hepatology; 2012 Jan; 55(1):39-48. PubMed ID: 21898483
[TBL] [Abstract][Full Text] [Related]
9. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.
Verstrepen BE; Nieuwenhuis IG; Mooij P; Bogers WM; Boonstra A; Koopman G
Clin Exp Immunol; 2016 Jul; 185(1):42-9. PubMed ID: 26850369
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
[TBL] [Abstract][Full Text] [Related]
12. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use.
Hotho DM; Kreefft K; Groothuismink ZM; Janssen HL; de Knegt RJ; Boonstra A
Antiviral Res; 2013 Mar; 97(3):347-55. PubMed ID: 23291200
[TBL] [Abstract][Full Text] [Related]
14. Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.
Anthony DD; Conry SJ; Medvik K; Sandhya Rani MR; Falck-Ytter Y; Blanton RE; Lederman MM; Rodriguez B; Landay AL; Sandberg JK
J Infect Dis; 2012 Sep; 206(6):969-73. PubMed ID: 22782948
[TBL] [Abstract][Full Text] [Related]
15. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
17. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
Yoon JC; Lim JB; Park JH; Lee JM
J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
[TBL] [Abstract][Full Text] [Related]
18. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR
Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318
[TBL] [Abstract][Full Text] [Related]
19. Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.
Pár G; Rukavina D; Podack ER; Horányi M; Szekeres-Barthó J; Hegedüs G; Paál M; Szereday L; Mózsik G; Pár A
J Hepatol; 2002 Oct; 37(4):514-22. PubMed ID: 12217606
[TBL] [Abstract][Full Text] [Related]
20. NKp30 isoforms in patients with chronic hepatitis C virus infection.
Mantovani S; Mele D; Oliviero B; Barbarini G; Varchetta S; Mondelli MU
Immunology; 2015 Oct; 146(2):234-42. PubMed ID: 26094914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
